Alexander Zeh

Alexander Zeh has a diverse work experience spanning various industries and roles. Alexander is currently the Head of Finance at Tacalyx GmbH, a Berlin-based biotech firm specializing in oncology, antibody discovery, and development. Prior to this, they co-founded Paricam Therapeutics, a biotech company focusing on periodontitis.

Alexander also has experience in senior financial roles in the pharmaceutical industry, having worked as a Senior Controller for drug development at Mologen AG. Alexander also worked in project management and bid management at Dornier Consulting International GmbH.

Before transitioning into the biotech and pharmaceutical sectors, Alexander gained experience in financial control and project management roles in the hospital services sector at VAMED and the real estate sector at Bouygues Immobilier. Alexander started their career as a trainee with Axel Springer SE, the leading German newspaper group.

Overall, Alexander Zeh's work experience showcases their expertise in finance, project management, and the biotech and pharmaceutical industries.

Alexander Zeh began their education in 1995 at Hochschule Mittweida, where they pursued a degree in Engineering & Management. Alexander successfully completed their studies in 2000 and was awarded a Diplom-Wirt.Ing. (Dipl.Ing.) degree. During their time at Hochschule Mittweida, Zeh also had the opportunity to study abroad at Università di Pisa in 1997-1998, focusing on Engineering coursework. In 2008, Zeh further expanded their education by enrolling at EBS Universität für Wirtschaft und Recht, specializing in Real Estate Management. Alexander completed their studies in this field in 2009.